Novo Nordisk A/S (NVO) and its wholly-owned affiliates on 31 March 2013 owned 19.66 million of its own B shares of DKK 1, corresponding to a total nominal value of DKK 19.66 million or 3.5% of the total share capital.
In the first quarter of 2013 a total of 3.1 million B shares were repurchased, and 834,490 B shares were disposed of to employees in connection with employee incentive programmes, the company said.
For comments and feedback: editorial@rttnews.com